Cargando…
miR-9 and miR-181a Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells
The incidence of liver cancer ranks seventh globally, with nearly half of all cases occurring in East Asia, but currently, there are very few drugs to treat it. Our previous studies demonstrated that the signal integration protein Gab2 is a potential drug target for the prevention and therapy of liv...
Autores principales: | Huang, Lantang, Liu, Ruimin, Zhou, Peiyi, Tian, Yingpu, Lu, Zhongxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690539/ https://www.ncbi.nlm.nih.gov/pubmed/36421826 http://dx.doi.org/10.3390/genes13112152 |
Ejemplares similares
-
Effect of miR-4270 Suppression on Migration in Hepatocellular Carcinoma Cell Line (HepG2)
por: Akrami, Hassan, et al.
Publicado: (2023) -
Data on the expression of PEPCK in HepG2 hepatocytes transfected with miR-195
por: Yang, Won-Mo, et al.
Publicado: (2017) -
Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways
por: Cheng, Jianghong, et al.
Publicado: (2017) -
Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells
por: Chen, Guang Shun, et al.
Publicado: (2016) -
Data on the decreased expression of FOXO1 by miR-1271 in HepG2 hepatocytes
por: Yang, Won-Mo, et al.
Publicado: (2017)